Affiliation:
1. Department of Zoology Mirpur University of Science and Technology Mirpur Pakistan
2. Department of Physics University of Kotli Azad Jammu and Kashmir Kotli Pakistan
3. School of Nuclear Science and Technology Lanzhou University Lanzhou China
4. Neurological Disorders Research Center, Qatar Biomedical Research Institute, Hamad Bin Khalifa University Doha Qatar
5. College of Health & Life Sciences Hamad Bin Khalifa University (HBKU) Doha Qatar
6. Institute of Human Genetics University Medical Center Göttingen Göttingen Germany
7. Institute for Auditory Neuroscience and Inner Ear Lab University Medical Center Göttingen Göttingen Germany
Abstract
AbstractHearing loss is a clinically and genetically heterogeneous disorder, with over 148 genes and 170 loci associated with its pathogenesis. The spectrum and frequency of causal variants vary across different genetic ancestries and are more prevalent in populations that practice consanguineous marriages. Pakistan has a rich history of autosomal recessive gene discovery related to non‐syndromic hearing loss. Since the first linkage analysis with a Pakistani family that led to the mapping of the DFNB1 locus on chromosome 13, 51 genes associated with this disorder have been identified in this population. Among these, 13 of the most prevalent genes, namely CDH23, CIB2, CLDN14, GJB2, HGF, MARVELD2, MYO7A, MYO15A, MSRB3, OTOF, SLC26A4, TMC1 and TMPRSS3, account for more than half of all cases of profound hearing loss, while the prevalence of other genes is less than 2% individually. In this review, we discuss the most common autosomal recessive non‐syndromic hearing loss genes in Pakistani individuals as well as the genetic mapping and sequencing approaches used to discover them. Furthermore, we identified enriched gene ontology terms and common pathways involved in these 51 autosomal recessive non‐syndromic hearing loss genes to gain a better understanding of the underlying mechanisms. Establishing a molecular understanding of the disorder may aid in reducing its future prevalence by enabling timely diagnostics and genetic counselling, leading to more effective clinical management and treatments of hearing loss.
Funder
Deutsche Forschungsgemeinschaft